We recently showed that anti-EGFR therapeutic antibody cetuximab is secreted with EVs by oral squamous cell carcinoma cells (4), suggesting that cancer cells could secrete redundant and toxic substances using this process. The gene discussed is EGFR; the disease is oral cavity squamous cell carcinoma.